Event Type
Disclosure
Amendment
Variant
8-K/A
Entry Into a Material Definitive Agreement. Merger Agreement As previously disclosed, on December 1, 2025, Apimeds Pharmaceuticals US, Inc, a Delaware corporati
Material Modification to Rights of Security Holders. The information set forth in Item 5.03 of this Amendment is hereby incorporated by reference into this Item
. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. The Company also determined that the Certificate of Designation filed with the Secre
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 2.1* Agreement and Plan of Merger, dated December 1, 2025, by and between Apimeds Pharma